PAPER Fuentealba J, Dibarrart AJ, Fuentes-Fuentes MC, Saez-Orellana F, Quiñones K, Guzmán L, Perez C, Becerra J, Aguayo LG
SEARCH RESULTS
331256 RESULTS
PAPER Proctor EA, Ding F, Dokholyan NV
Structural and thermodynamic effects of post-translational modifications in mutant and wild type Cu, Zn superoxide dismutase.
J Mol Biol. 2011 May 6;408(3):555-67. PubMed: 21396374PAPER Vanguilder HD, Freeman WM
The hippocampal neuroproteome with aging and cognitive decline: past progress and future directions.
Front Aging Neurosci. 2011;3:8. PubMed: 21647399PAPER Boutahar N, Wierinckx A, Camdessanche JP, Antoine JC, Reynaud E, Lassabliere F, Lachuer J, Borg J
Differential effect of oxidative or excitotoxic stress on the transcriptional profile of amyotrophic lateral sclerosis-linked mutant SOD1 cultured neurons.
J Neurosci Res. 2011 Sep;89(9):1439-50. PubMed: 21647936PAPER Na H, Acharjee S, Jones G, Vivithanaporn P, Noorbakhsh F, McFarlane N, Maingat F, Ballanyi K, Pardo CA, Cohen EA, Power C
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.
Retrovirology. 2011;8:44. PubMed: 21645334PAPER Cabriolu R, Auer S
Amyloid fibrillation kinetics: insight from atomistic nucleation theory.
J Mol Biol. 2011 Aug 5;411(1):275-85. PubMed: 21645521PAPER Voronkov M, Braithwaite SP, Stock JB
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.
Future Med Chem. 2011 May;3(7):821-33. PubMed: 21644827PAPER Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain.
J Neurochem. 2011 Aug;118(4):658-67. PubMed: 21644996PAPER Articus K, Baier M, Tracik F, Kühn F, Preuß UW, Kurz A
A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
Int J Clin Pract. 2011 Jul;65(7):790-6. PubMed: 21645184PAPER Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Clos AL, Jackson GR, Kayed R
Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.
Mol Neurodegener. 2011;6:39. PubMed: 21645391PAPER Pignataro G, Capone D, Polichetti G, Vinciguerra A, Gentile A, Di Renzo G, Annunziato L
Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options.
Curr Opin Pharmacol. 2011 Aug;11(4):378-94. PubMed: 21646048PAPER Weiner MW, Sadowsky C, Saxton J, Hofbauer RK, Graham SM, Yu SY, Li S, Hsu HA, Suhy J, Fridman M, Perhach JL
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease.
Alzheimers Dement. 2011 Jul;7(4):425-35. PubMed: 21646051PAPER Jefferson T, Čaušević M, Auf dem Keller U, Schilling O, Isbert S, Geyer R, Maier W, Tschickardt S, Jumpertz T, Weggen S, Bond JS, Overall CM, Pietrzik CU, Becker-Pauly C
Metalloprotease meprin beta generates nontoxic N-terminal amyloid precursor protein fragments in vivo.
J Biol Chem. 2011 Aug 5;286(31):27741-50. PubMed: 21646356PAPER Gao L, Zeng XN, Guo HM, Wu XM, Chen HJ, Di RK, Wu Y
Cognitive and neurochemical alterations in hyperhomocysteinemic rat.
Neurol Sci. 2011 Jun 7; PubMed: 21647626PAPER Jicha GA
Medical management of frontotemporal dementias: the importance of the caregiver in symptom assessment and guidance of treatment strategies.
J Mol Neurosci. 2011 Nov;45(3):713-23. PubMed: 21647712Current Filters
No filters selected